Elevation Oncology names Joseph Ferra CEO, Tammy Furlong CFO

Elevation Oncology appointed Joseph Ferra as its CEO. Ferra was previously Interim CEO and CFO. Ferra will also join the Elevation Oncology Board of Directors. In addition, the company appointed Tammy Furlong as CFO, promoted from her previous role as Vice President of Finance and Accounting. Ferra previously served as CFO of Syros Pharmaceuticals, leading and coordinating financial and capital strategies and operational aspects for the company. Prior, he spent over a decade working in biotechnology and pharmaceutical investment banking, and he served as Managing Director and Co-Head of Healthcare Investment Banking at JMP Securities and was a member of the investment banking groups at JP Morgan and UBS. In 2021, he became CFO of Elevation and in January of 2023, he was appointed Interim CEO. Furlong has served as the Vice President of Finance and Accounting at Elevation Oncology, leading its financial and operational teams since 2021. Prior to Elevation Oncology, she was a finance consultant for multiple biotechnology and pharmaceutical companies.